← brief for 2026-08-12 · Slowing decline

Semaglutide/Acarbose combination protects against diabetic nephropathy in rats; a novel insight into modulation of Nrf-2/HO-1& TGF-β/Smad pathways.

Article D Peer reviewed Preclinical

Key takeaways

Researchers gave rats with diabetic kidney damage a mix of two diabetes drugs, semaglutide and acarbose. The combination seemed to protect the kidneys and calm the pathways that drive scarring. This was done in rats, not people, so it is very early.

Who did this work

Elborei MA · Ashour AA · El-Latif HAEA · Akool ES

Source

Article · PubMed, the drug frontier · 2026 Aug 11
https://pubmed.ncbi.nlm.nih.gov/42580144/